D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea
· Delayed Price · Currency is KRW 48,150
+2,200 (4.79%)
Apr 1, 2025, 3:30 PM KST
D&D Pharmatech Revenue
In the year 2024, D&D Pharmatech had annual revenue of 11.44B KRW, down -38.77%. D&D Pharmatech had revenue of 5.06B in the quarter ending December 31, 2024, with 180.01% growth.
Revenue
11.44B
Revenue Growth
-38.77%
P/S Ratio
40.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
485.60B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |